Etu esi ewere ọgwụ Maninil na gịnị bụ ọnụ ahịa ya na ụlọ ahịa ọgwụ?

Glibenclamide na-akpali mmepụta nke insulin ma na - abawanye mmetụta ọgwụ insulin glucose.

N'okpuru mmetụta nke ọgwụ ahụ, mmetụta nke mkpụrụ ndụ pancreatic na polypeptide glucose insulinotropic glucose na-abawanye.

A na-enweta nsonaazụ extrapancreatic site na ịbawanye uche nke ndị na-anabata ya na insulin.

Na usoro ọgwụgwọ ọgwụgwọ, mannyl na-ebelata ohere nke nsogbu dị ka nephropathy, retinopathy, cardiopathy, na-ebelata onwu n’aria oria shuga.

Ọgwụ nwere antiarrhythmic na cardioprotective Ime ihe na -eme ka ọ bụrụ ndị ọrịa shuga na-arịa ọnya obi.

Glibenclamide na-ebelata nchịkọta platelet, na-egbochi nsogbu nke ọrịa shuga.

Ọgwụ dị irè karịa ihe karịrị awa iri na abụọ. N'ime ụdị nke micronized, a na-enweta glibenclamide ngwa ngwa site na nri diges, nke na-eme ka ọgwụ ahụ nwee ike ịmekwu ahụ ma jiri nwayọọ.

Mwepụta wepụtara ya na ihe mejupụtara

Indị Maninil na usoro onodu ogwu bu mbadamba: cylindrical ewepụghị, pink na agba, ya na bevel na chamfer n’otu akụkụ (PC. 120 N’ karama nke iko enweghi agba, karama 1 n’otu kaadiboodu).

Ihe na-arụ ọrụ nke ọgwụ ahụ bụ glibenclamide (n'ụdị micronized). N'ime mbadamba 1 ọ nwere 1.75 mg, 3.5 mg ma ọ bụ 5 mg.

Mbadamba ụrọ 1.75 na 3.5 mg: stachi nduku, lactose monohydrate, hemetellose, magnesium stearate, colloidal silicon dioxide, sọks (Ponceau 4R) (E124),
Mbadamba mbadamba 5 mg: gelatin, talc, stachi nduku, lactose monohydrate, magnesium stearate, diceson (Ponceau 4R) (E124).

Ihe ngbanwe

Ọrịa shuga 1dị 1
Ọrịa mamịrị precca na coma
Ọrịa mamịrị ketoacidosis
Ọnọdụ mgbe anụ ahụ yiri,
Enweghị nri glucose-6-phosphate
Nlere na ịhe eji akpata oyi n'ahụ, ụkọ lactase, ọrịa glucose / lactose malabsorption,
Paresis nke afọ, mgbochi afọ,
Ọdịda akụrụ gbasara nnukwu (mwepu nke na-erughị 30 ml / nkeji),
Ọrịa imeju siri ike,
Leukopenia
Mmebi nke metabolism metabolism mgbe a warachara ya ahụ, maka ọkụ, mmerụ ahụ na ọrịa na-efe efe, ọ bụrụ na egosiri ọgwụ insulin,
N’agbata afọ 18
Ime
Lactation
Akpachapụ anya na akụkụ nke ọgwụ ahụ ma ọ bụ probenecid, ihe ndị nwere mkpụrụ ndụ sulfonamide n'ime molekul, sulfonamides na usoro nke sulfonylurea ndị ọzọ.

Mmekọrịta (nlekọta ọzọ chọrọ):

Ọrịa thyroid gland, tinyere mebiri ọrụ ya,
Hypofunction nke eriri afọ adrenal ma ọ bụ ntụ ntụ,
Ọrịa Febresi
Mmanya na-egbu egbu,
Mmanya na-egbu egbu
Afọ karịrị afọ iri asaa.

Usoro onunu ogwu na nhazi

Mkpebi Maninil kpebisiri ike dabere ogo usoro ọrịa ahụ, afọ onye ọrịa yana itinye glucose n'ọbara na afọ na-enweghị nri na awa 2 mgbe nri gasịrị.

Were ọgwụ tupu nri, na-a plentyụ ọtụtụ mmiri. Ọ bụrụ na ọ dị mkpa, enwere ike ikewaa mbadamba ahụ na ọkara, mana enweghị ike ita ata ma ọ bụ gwepịa ya. A na-atụkarị ọgwụ kwa ụbọchị ruo mbadamba abụọ ruo ụbọchị iri abụọ - tupu nri ụtụtụ. A na-ekewa usoro ogwu dị elu ka usoro 2 - n'ụtụtụ na mgbede.

Usoro izizi nwere ike ịbụ site na 1.75 mg ruo 5 mg. Ọ bụrụ na mmetụta ahụ ezughi oke, n'okpuru nlekọta dọkịta, a na-eji nwayọọ nwayọọ mụbaa ọgwụ ahụ ka ọ kachasị, nke ga-eme ka metabolism metabolism dị ike. A na-eme mmụba nke dose ahụ na etiti oge site na ọtụtụ ụbọchị ruo izu 1. Oke kacha anabata kwa ụbọchị bụ 10.5 mg (mbadamba 6 1.75 mg ma ọ bụ 3 mbadamba 3.5 mg). N'ọnọdụ ụfọdụ, a na-ahapụ ya ka ọ nwekwuo ọgwụ kwa ụbọchị ka 15 mg (3 mbadamba 5 mg).

Ibufe onye ọrịa na Maninil site na ọgwụ hypoglycemic ọzọ ka a na-eme n'okpuru nlekọta nke dọkịta, bido na nke kacha nta, jiri nwayọ na-abawanye ya na usoro ọgwụgwọ dị mkpa.

Okenye, ndi adighi ike na ndi oria na erughi nri nri, ya na ndi oria nwere akwara ma obu oria obi ha, ma ndi nke izizi ya na ndi mmezi ya. ha nwere ihe ize ndụ nke ịmalite hypoglycemia.

Ọ bụrụ n’ịfịa ọgwụ nke ọzọ, were ọgwụ n’oge a na-emebe ya, a machibidoro ya ị doseụ okpukpu abụọ!

Nsonaazụ

Metabolism: ọtụtụ mgbe - mmụba n’arụ, hypoglycemia (hyperthermia, iru mmiri nke anụ ahụ, adịghị ike, iro ụra, agụụ, nhazi nke mmegharị, nchekasị n'ozuzu oke, isi ọwụwa, ịma jijiji, echiche nke ụjọ, tachycardia, nsogbu adịghị ala, gụnyere paresis ma ọ bụ ahụ mkpọnwụ, mgbanwe banyere nghọta, nsogbu na echiche n'ọhụụ)
Usoro nri: enweghi oge - uto dị n'ọnụ, afọ mgbu, mmetụta nke ibu dị na afọ, ọgbụgbọ, afọ ọsịsa, na -emegharị, vomiting,
Imeju na ọnya biliary: ọ na - adịkarịghị - intrahepatic cholestasis, mmụba nwa oge na ọrụ nke enzymes imeju, ịba ọcha n'anya,
Hematopoietic sistemu: adịkarịghị - thrombocytopenia, ọ dịkarịsịrị ike - agranulocytosis, erythropenia, leukopenia, n'ọnọdụ ndị dịpụrụ adịpụ - ọbara ọgbụgba hemolytic, pancytopenia,
Sistemụ: Ọrịa na - adịghị ala ala - purpura, urticaria, ịmụba amụba, petechiae, itching, adịkarịghị - anaphylactic ujo, vasculitis nfụkasị ahụ, mmeghachi omume nfụkasị ahụ, tinyere fever, ọnya anụ ahụ, proteinuria, arthralgia na jaundice,
Ndị ọzọ: ọ na - adịkarịke - mmụba diureis, hyponatremia, proteinuria, nsogbu nke ebe obibi, imerụ anya, mmeghachi omume disulfiram dịka ị na - a alcoholụ mmanya (nke a na - egosikarị site na mgbaàmà dịka ihu nke ihu na elu elu, mgbu afọ, ọgbụgbọ, ọgbụgbọ, ọgbụgbọ, ọgbụgbọ, isi ọwụwa, tachycardia), nfụkasị ahụ na-eme ka sulfonamides, sulfonylureas, probenecid, diuretics nwere otu sulfonamide n'ime molekul.

Ntụziaka pụrụ iche

Oge ọgwụgwọ niile, ọ dị mkpa ịrapagidesie ike n'ihe ndị dọkịta kwuru maka nyocha nke onwe nke mgbanye glucose ọbara na nri, iji zere ikpughe anyanwụ.

Ekwesịrị icheta na mmega ahụ siri ike, inye carbohydrates ezughi oke, ịhapụ ị abstụ nri, yana ịgbọ agbọ na afọ ọsịsa bụ ihe ndị dị ize ndụ hypoglycemia.

N'ime ndị okenye, enwere ike ịmalite hypoglycemia dị ntakịrị karịa, yabụ, ha chọrọ nhọrọ nlezianya karịa na nyochaa oge itinye uche glucose ọbara, karịsịa na mmalite ọgwụgwọ.

Peripheral neuropathy ma n'otu oge ahụ ọgwụ ndị nwere mmetụta na sistemụ akwara etiti, na-ebelata ọbara mgbali elu (gụnyere beta-blockers), nwere ike kpuchie mgbaàmà hypoglycemia.

Ethanol nwere ike ibute mmepe nke hypoglycemia na mmeghachi omume disulfiram, yabụ n'oge ọgwụgwọ ọ dị mkpa izere ị beụ mmanya na-aba n'anya.

Ọrịa na-efe efe yana ọrịa febrile, oke ọkụ, mmerụ ahụ na ịwa ahụ nwere ike ịchọ ịkwụsị ọgwụ na nhọpụta insulin.

N'oge ọgwụgwọ, a na-adụ ọdụ mgbe ị na-anya ụgbọ ala ma na-etinye aka n'ihe ndị nwere ike ibute nsonaazụ ya, nke chọrọ ọsọ ọsọ na nlebara anya.

Mkparịta ụka ọgwụ ọjọọ

Ọgwụ ndị na-esote nwere ike ịkwalite nsonaazụ nke Maninil: insulin na ọgwụ ọgwụ hypoglycemic ndị ọzọ, ọgwụ coumarin, angiotensin-na-agbanwe enzyme inhibitors, ọgwụ quinolone, inhibitors monoamine, ọgwụ antifungal (fluconazole, miconazole), clofibrate ya analorop, azon, azon, azon, azon, azon, azon, azon, azon, azon, azon, azon, azon, azon, azon, azon, azon, azone, azon, azone, azone , beta-igbochi, fenfluramine, nnupụisi, fluoxetine, probenecid, tetracyclines, sulfonamides, salicylates, tritocvalins, usoro nke irazolones, perhexiline, phosphamides (dịka eg ifosfamide, cyclophosphamide, trophosphamide), ọgwụ anabolic na homonụ nwoke na nwanyị, pentoxifylline (na oke ọnụọgụ maka ojiji nke parenteral), na nkwanye acid acid (calcium chloride, ammonium chloride).

N'otu oge na mmụba na hypoglycemic mmetụta, reserpine, guanethidine, clonidine na beta-blockers, yana ọgwụ nwere usoro ihe eji eme ihe, nwere ike belata ogo nke mgbaàmà na-ebute hypoglycemia.

Ọgwụ ndị na-esote nwere ike belata nsonaazụ Maninil: glucocorticosteroids, nicotinates (na nnukwu doses), barbiturates, mgbochi mgbochi calcium, ọgwụ mgbochi ụkwara ume na estrogens, ọgwụ homonụ, mmiri nnu, lithium salts, sympathomimetics, thiazide diuretics, glucagon, phenothiazines, , acetazolamide, rifampicin, isoniazid.

Antagonists nke N₂ndị na-anabata ya nwere ike ịkwalite ma mee ka ike gwụ hypoglycemic mmetụta nke ọgwụ.

Maninyl nwere ike ịkụda ma ọ bụ kwalite ọrụ nke usoro nke coumarin.

A na - amata ikpe dị iche iche mgbe pentamidine kpatara mmụba dị elu ma belata n'ọbara glucose n'ọbara.

Mlọ ọgwụ

Maninyl 3.5 na 1.75: nnabata si eriri afọ bụ ngwa ngwa ma na-ezuzu oke. Mwepụta nke micronized nọ n'ọrụ ihe n'uju pụtara na nkeji ise,
Maninil 5: ogo nke nnabata si eriri afọ - site na 48 ruo 84%. Oge iru C_max –1-2 awa. Ezigbo bioavailability sitere na 49 ruo 59%.

Na-agbanye na protein protein: Maninyl 3,5 na 1,75–7 karịa 98%, Maninyl 5 - 95%.

Glibenclamide fọrọ nke nta ka ọ bụrụ metabolized n'ime imeju, yana nguzobe metabolites abụọ na-adịghị arụ ọrụ. Igbuputa otu n’ime ha na - ewere mmetu bile, nke abuo - ya na mmamiri.

Ndi_1/2 (ọkara ndụ): Maninil 1.75 na 3.5 - 1.5-3.5 awa, Maninil 5 - site na awa 3 ruo 16.

Maninil, ntuziaka maka ojiji: usoro na usoro onunu ogwu

Mmanụ mbadamba Maninil bụ nke a na-ewere n'ọnụ iji na-ata ata ma na-a withụ ya na obere mmiri mmiri, ọkacha mma tupu nri. Ọ bụrụ na ọgwụ kwa ụbọchị bụ mbadamba 1-2, a na-ewere ya otu ụtụtụ, ozugbo nri ụtụtụ. Ekwesịrị iwere usoro dị elu na usoro onyonyo abụọ (ụtụtụ na mgbede).

Ọ bụrụ n ’ịfugharị otu nchịkwa nke Maninil, a ga-ewere mbadamba na-esote n’oge a na-emebu, na-enweghị ịba ụba dose ahụ.

Usoro ikpe nke ọgwụ a ka ana-ekpebi afọ, oke ọrịa ahụ, ịba ụba nke glucose n'ọbara na afọ efu na awa 2 mgbe nri gasịrị.

N'ọnọdụ ezighi ezi nke usoro ọgwụ enyere, ka ana eleba ya anya, ọ na - abawanye (site na ọtụtụ ụbọchị ruo otu izu) rue mgbe a ga - eme ka metabolism zuru oke mee ka ọ kwụsie ike (mana ọ bụghị karịa nke kachasị).

Mgbe ọ na-agbanwe site na ị takingụ ọgwụ hypoglycemic ndị ọzọ, a na-edenye Maninil na usoro izizi nke mbụ n'okpuru nlekọta ahụike yana mmụba nwayọ nwayọ nwayọ ruo kachasị mma.

Thebọchị kwa ụbọchị (nke mbụ / nke kachasị) bụ:

Maninyl 1.75: 1.75-3.5 / 10.5 mg (ma ọ bụrụ na ị na-eme kwa ụbọchị karịrị mbadamba 3, a na-atụ aro iji Maninil 3.5),
Maninyl 3,5: 1.75-3.5 / 10.5 mg,
Maninyl 5: 2.5-5 / 15 mg.

N'ihi ihe egwu nke ibute ọrịa hypoglycemia na ndị ọrịa agadi, na-enwe nnukwu ọrụ nke imeju ma ọ bụ akụrụ, ndị ọrịa na-arịa ọrịa na-enweghị nsogbu, a ga-ebelata mbido na mmezi nke usoro ọgwụ Maninyl.

Mbadamba Maninil, ntuziaka maka ojiji (usoro na usoro onunu ogwu)

A na-ahọrọ ọgwụ Maninil n'otu n'otu, na-eburu n'uche ụzọ ọrịa ahụ dị, afọ onye ọrịa, yana shuga ọbara. Ihe nkezi ubochi ubochi bu 2.5-15 mg. A na-ewere Glibenclamide n'ụtụtụ na mgbede ọkara elekere tupu nri, n'enweghị mkpa ịta ata.

Dabere na ntuziaka maka ojiji, enwere ike iji Maninil 5 mee ihe kachasị oke nke mbadamba 3-4 kwa ụbọchị.

Dodoụbiga ya ókè

Ọsụsọ mụbara, agụụ, onye ntị chiri, ọgụgụ isi, ọhụụ, ịma jijiji, palpitations, iwe iwe, ehighị ụra nke ọma, ịda mbaakụkụ ụbụrụ na ihe ịrịba ama ndị ọzọ hypoglycemiaComa.

Ọgwụ: were shuga n’ime. Ọ bụrụ na onye ọrịa amaghị onwe ya, mgbe ahụ intravenly gbasaa dextrose bolus, glucagon, diazoxide. Kwa minit 15 nyochaa ọkwa glucose ọbara. Iji gbochie re-hypoglycemia, ọ dị mkpa inye nri onye ọrịa bara ụba na carbohydrates (digestible na-adị mfe). Mgbe edepụtara ụbụrụ ụbụrụ dexamethasonemannitol.

Mmekorita

Ọgwụ Antifungal, ACE inhibitors, NSAID, fibrates, ọgwụ mgbochi TB, anticoagulants ahịrị coumarin salicylates, beta-igbochi, anabolic steroid, MAO inhibitors, biguanides, fenfluramine, tetracycline, chloramphenicol, pentoxifyllinecyclophosphamides, acarboses, pyridoxine, nnupụisi, bromocriptine, reserpine, allopurinol, insulin welie mmetụta Maninil.

Adrenostimulants, barbiturates, ọgwụ antiepileptik, carbon anhydrase inhibitors, BMCC, chlortalidonethiazide diuretics, furosemide, baclofenglucagon, terbutaline, asparaginase, danazol, isoniazid, rithodrin, morphine, salbutamol, diazoxide, danazole, ritodrin, glucagon, homonụ thyroid, rifampicin, chlorpromazine, nicotinic acid, lithium salts, estrogens, ọgwụ mgbochi mkparị na-akụda mmetụta dị mma nke Maninyl.

Akwa doses acid nke ascorbic, ammonium chloride mụbaa reabsorption nke ọgwụ ahụ, na-eme ka mmetụta nke glibenclamide dịkwuo elu.

Site na nchịkwa oge a na ọgwụ ndị na-egbochi ụmị ọkpụkpụ, a na-achọpụta ọghọm ka ukwuu myelosuppression.

Ihe ngosi maka ojiji

Edere ọgwụ ahụ n'ọnọdụ ụfọdụ usoro ndị ọzọ, dị ka mmega ahụ na-adịghị agafe agafe, nri nwere shuga dị ala, oke ibu anaghị emetụta ọkwa glucose n'ọbara, na-eduga ya na usoro physiological nkịtị. A na - egosi ọgwụ nwoke nke ọrịa shuga Maninil maka ndị na - abụghị insulin na - enwe ụdị ọrịa shuga 2.

Uzo esi ewere Maninil

Withgwọ ọgwụ na ọgwụ kwesịrị iji obere doses malite iji zụlite hypoglycemia. Usoro izizi bụ ọkara mbadamba 1 nke Maninil kwa ụbọchị. Ọ dị mkpa ileba anya n'ọkwa glucose dị n'ọbara iji zere ịba ụba hypoglycemia, ọkachasị maka ndị asthenic nwere nri dị ala. Ọ bụrụ n’ịtachara ọgwụ a, ọ̀tụ̀tụ̀ shuga dị n’ọbara anaghị agbadata, mgbe ahụkwa ihe dị ka izu 1, ọ̀gà ahụ na-abawanye.

E kwesịrị iburu mbadamba n'ụtụtụ n'ụtụtụ efu, ihe dị ka nkeji 20-30 tupu nri, were iko mmiri sachaa ya. Ọ bụrụ na endocrinologist depụtara ọgwụ kwa ụbọchị nke mbadamba 2, mgbe ahụ ekee ihe ha na-ebute na ugboro abụọ: n'ụtụtụ na anyasị, oge niile n'otu oge. Ka ị na-a thisụ ọgwụ a, ọ dị mkpa inyocha ọbara ọbara gị na mmamịrị glucose kwa izu.

Analoo maninil

N'ime ụlọ ahịa ọgwụ, ịnwere ike ịzụta ọgwụ nwere otu ma ọ bụ ihe ndị ọzọ na-arụ ọrụ na ntinye aka. A na-akpọ ọgwụ ndị a analogues nke Maninil, ha nwere otu ma ọ bụ otu mmetụta na ahụ, dabere na ihe mejupụtara. Ihe ndi a bu ihe ndi a na agbanwe agbanwe nwere ihe ndi glibenclamide ma obu ihe ndi ozo yiri ya:

Mbadamba nke Glibenclamide,
Mbadamba akwụkwọ ndụ glidiab
Mbadamba nkume Diabefarm MV.

Ọnụ ego Maninil

Mgbe ị na-azụ ọgwụ ọ bụla, ọ dị mkpa ị attentiona ntị na ndị nrụpụta, ihe mejupụtara, nyocha. Mgbe ị na-ekpebi iji dochie Maninil na analog, jide n'aka na ị gakwuru onye endocrinologist. Ego a na-akwụ maka ọgwụ hypoglycemic a karịrị akarị - ọ dị ọnụ ala. N'okpuru bụ okpokoro nwere ọnụego ọgwụ na Moscow.

Mbadamba Maninil 5 mg

Mbadamba Maninil 3.5 mg

Erere Maninil 1.75

Olesya, 48 Maninil 5 Enyere m ọgwụ maka ịgwọ ụdị ọrịa shuga 2. M na-eji ọgwụ ahụ ike dabere na ntuziaka. Na mgbakwunye, m na-a otherụ ọgwụ ndị ọzọ na-ebelata shuga, ana m agbaso nri siri ike, na-eme ihe na-adịghị na-ewepu nri nwere shuga, ana m anwa ịkwaga karịa. Usoro shuga dị nkịtị.

Natalya, 26 Mbadamba Maninil ka enyere n’aka nna m ochie, na-arịa ọrịa shuga ruo ihe karịrị afọ 5. M zụtaara ya ọgwụ a maka afọ nke abụọ. Ọgwụ ahụ akpataghị nsonaazụ ọ bụla, naanị ihe anyị mere na mbụ dị ka ntụziaka dọkịta si dị bụ iburu mbadamba 1 kwa ụbọchị maka ọnwa isii, mgbe ahụ, n'ihi nrụgide, gbanwere gaa 2.

Andrey, 35 Nna m nwere ụdị ọrịa shuga abụọ nke ọrịa shuga, ọ naghị enwe ihe ịga nke ọma na-eri nri oge niile, gbakwunyere na ọ naghị emega ahụ, ọ na-ebi ndụ enweghị ike ịnọ nkịtị. Drugsdị ọgwụ dọkịta ahụ edeghị maka anyị, mana, n'echiche m, Maninil 3.5 mechara bụrụ nke kachasị arụ ọrụ. Papa m nwere ahụ iru ala karị, ọkwa shuga dị n'ọbara belatara.

Jiri nlezianya

A ga-akpachara anya n'ụdị ndị a:

nsị thyroid,
ihe ọdịdọ ahụ ọdịdọ na ọdịdọ,
ediyarade nke ihe ịrịba ama nke hypoglycemia,
dịgasị iche iche nke egbu egbu nke ahụ.

N'ime oge ọgwụgwọ niile, a na-enyocha nyocha nke ndị ọrịa na ọnụnọ nke usoro ahụ dị n'elu.

Site n'akụkụ nke metabolism

Enwere agụụ agụụ na-achịkwa, mmụba nke ahụ, isi ọwụwa, adịghị ike nke itinye uche, mebie usoro nhazi nke ikpo ọkụ. Theakingụ ọgwụ ahụ nwere ike iduga mmepe nke hypoglycemia.

Mgbe ị na-ewere Maninil, isi ọwụwa na-apụta. Ekwesịrị ịgwọ ọrịa n'okpuru nlegide anya nke dibia na ịchekwa shuga ọbara mgbe niile.

Mmetụta ikike ịchịkwa usoro

Mgbe ị na-a theụ ọgwụ ahụ, a na-atụ aro ka ọ ghara ịnya ịnya ụgbọ ala na ịme ihe ndị metụtara usoro ndị nwere ike imebi emebi. Ngwaahịa a nwere ike ibute iro ụra ma ọ bụ ure.

Mgbe ị na-a theụ ọgwụ ahụ, a na-atụ aro ka ọ ghara ịkwọ ụgbọala. Ngwaahịa a nwere ike ibute iro ụra ma ọ bụ ure.

Jiri na agadi

N’oge agadi, enwere ihe ọghọm nke ịmalite hypoglycemia. Ekwesịrị ịgwọ ọrịa n'okpuru nlegide anya nke dibia ma tụọ ọkwa shuga dị n'ọbara oge niile.

N'oge ịka nká, a ga-eme ọgwụgwọ na Maninil n'okpuru nlekọta nke dọkịta ma tụọ ọkwa shuga dị n'ọbara oge niile.

Mmanya ndakọrịta

Mgbe ejikọtara ya na mmanya nwere mmanya, ọgwụ ahụ nwere ike ibute hypoglycemia. N'oge usoro ọgwụgwọ, a ga-ewepụ ihe ọ alcoholụ alcoholụ na-aba n'anya.

Ọgwụ a nwere analogues na usoro ọgwụ:

Amaril yiri nke ahụ na Maninil.

Maka nke ọ bụla n'ime ha, ntuziaka ahụ na-egosi contraindications na nsonaazụ ndị ọzọ. Tupu ị dochie akara analog, ịkwesịrị ịga hụ dọkịta wee nyocha.

Nyocha banyere Maninil 3.5

A na-enye ọgwụ ọgwụ Maninil 3.5 mg na mgbakwunye na nri na ndụ ike. Ndị ọrịa na-achọpụta nsonaazụ ngwa ngwa, yana ndị dọkịta - enweghị mmetụta ndị na-adịghị mma mgbe ị na-agbaso ntuziaka.

Oleg Feoktistov, endocrinologist

Maka ụdị shuga 2, ana m enye ndị ọrịa ọgwụ a. N'okpuru mmetụta nke ọgwụ ahụ, ọnụọgụ shuga dị n'ọbara na-ebelata, n'ihi na imeju na akwara amalite ịmịkọrọ glucose. Ọ nabatara ọgwụ ahụ nke ọma. Site n'iji ya eme ihe mgbe niile, ọ na-eme ka ntọhapụ nke insulin nwee ike ma nwee mmetụta antiarrhythmic.

Kirill Ambrosov, onye na-agwọ ọrịa

Ọgwụ nwere ike belata onwu n’etiti ndị ọrịa nwere ọrịa shuga. Erere na enyere aka ime ka glucose di n’obara ọbara, belata ihe cholesterol “nke jọrọ njọ”. A na-etinye nri dị n'ọrụ ngwa ngwa, ihe ahụ wee ruo awa 24. Iji zere ịba ụba, ị ga-emega ahụ ma rie ya nke ọma.

Ndị ọrịa mamịrị

Tatyana Markina, onye gbara afọ 36

E kenyere ya otu mbadamba ụbọchị. Ngwá ọrụ ahụ na-enyere aka ịchịkwa ọkwa shuga. Ana m agbaso nri obere carb ma na-anwa ịgagharị mgbe niile. N'ime ọnwa 4 nke ọgwụgwọ, ọnọdụ ahụ kawanyere mma. Otu n'ime nsogbu ndị ọ na-akpata bụ ọrịa stool na migraine. Ọrịa na-apụ n'anya ka izu abụọ gachara. Achọrọ m ịga n'ihu na nnabata.

Anatoly Kostomarov, 44 afọ

Dọkịta dere ọgwụ maka ọgwụ maka ọrịa shuga na-arịa insulin na-abụghị insulin. Ahụghị m mmetụta nsonaazụ, belụsọ ọgbụgba. Ekwesịrị m belata usoro ị theụ ọgwụ na ọkara ọgwụ. Sugar bụ ihe dị mma ma na-atọ ụtọ. Ana m akwado ya.